cervical cancer screening tests and cancer precursors. Barbara Crothers, DO; Teresa Darragh, MD; Maria Demarco, PhD; Eileen Duffey-Lind, MSN; Ysabel Duron, BA; Didem Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Clinical judgment should always be used when applying a guideline to an individual patient because it is impossible Available at: ASCCP. 6) The last screen shows the guidelines information for this patient. A Pap test, also called a Pap smear or cervical cytology, is a way of screening for cervical cancer. Obstet Gynecol 2013;121:82946. 2020 Jul-Aug;9(4):291-303. doi: 10.1016/j.jasc.2020.05.002. may email you for journal alerts and information, but is committed This evaluation may include cervical cytology, colposcopy, diagnostic imaging, and cervical, endocervical, or endometrial biopsy. Participating organizations and N.W.) After a diagnosis of high-grade histology or cytology, patients may undergo hysterectomy for reasons related or unrelated to their cervical abnormalities.If hysterectomy is performed for treatment, patients should have 3 consecutive annual HPV-based tests before entering long-term surveillance. -, Massad LS, Einstein MH, Huh WK, et al. Available at: ASCCP management guidelines app quick start guide. The updated management guidelines aim to: Although the guidelines are based on evidence whenever possible, for certain clinical situations, there is limited 2f8 Hf8*@r9MXNw6JXbc```3=20(.bbc`Sb0 Z endobj Bookshelf In patients 21 to 29 years of age, cervical cancer screening should be performed every three years using cervical cytology alone. Although the guidelines are based on evidence whenever possible, for certain clinical situations, there is limited Copyright, 2002, 2006, 2013, 2019, 2020, 2021 ASCCP. However, if performed, abnormal vaginal screening test results should be managed according to published recommendations (BII).Perkins RB, Guido RS, Castle PE, et al. We don't have any prior history in this particular case. these guidelines. The application uses data and recommendations from the following sources: The recommendation is for colposcopy. Funding for these activities is for the research related costs of the trials. Cervical cancer screening with Pap and/or human papillomavirus (HPV) tests is recommended starting between the ages of 21 and 25 years. Schiffman, Wentzensen: The National Cancer Institute (incl. Repeat Pap 12 m if referral Pap was LSIL Preferred Approach Colposcopy @ 6 m if referral Pap was ASC-H or moderate Treatment: Decision to treat is based on patient and provider preferences Negative or CIN 1 Discharge, Repeat Pap @ 12 months Moderate or marked referral Pap - see Guideline Ib. %%EOF Who developed these guidelines? cotesting at intervals <5 years, or cytology alone at intervals <3 years. 5. Przybylski M, Pruski D, Millert-Kaliska S, Krzyaniak M, de Mezer M, Frydrychowicz M, Jach R, urawski J. Biomedicines. The guidelines effort received support from ASCCP and the National Cancer Institute. If everything is correct, click next and move on to the recommendations page. Please enable it to take advantage of the complete set of features! Because the new Risk-Based W.K.H. Therefore, we click no for prior history and click next. 5 - 8 New algorithms focus on special populations (i.e., adolescents and . New data indicate that a patient's Epub 2020 May 23. Erin Nelson, MD; Akiva Novetsky, MD, MS; Rebecca Perkins, MD; Jeffrey Quinlan, MD; Mona Saraiya, MD; Debbie Saslow, HPV-based testing: this term is used in this document to describe the use of either cotesting or primary HPV No industry funds were used in the development of No industry funds were used in the development of these guidelines. Read all of the Articles Read the Main Guideline Article Management Guidelines For additional quantities, please contact [emailprotected] The clinical management recommendations were last updated on 01/25/2022. The updated management guidelines aim to: Allow for a more complete and precise estimation of risk Provide more appropriate intervention for high-risk individuals (detect and treat more. ASCCP Management Guidelines Web Application Welcome to the ASCCP Management Guidelines Web Application! Bulk pricing was not found for item. See permissionsforcopyrightquestions and/or permission requests. HPV testing or cotesting at more frequent intervals than are recommended for screening. that incorporation of the risk-based approach can provide more appropriate and personalized management for an Get new journal Tables of Contents sent right to your email inbox, Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors, Articles in PubMed by Rebecca B. Perkins, MD, MSc, Articles in Google Scholar by Rebecca B. Perkins, MD, MSc, Other articles in this journal by Rebecca B. Perkins, MD, MSc, 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors, The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines, 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors: Erratum, An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines, 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation, Privacy Policy (Updated December 15, 2022), American Society for Colposcopy and Cervical Pathology. to routine screening. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. Perkins RB, Guido RS, Castle PE, et al. As of April 2021, the cost for the mobile app is $10. Vaccination is ideally administered at 11 or 12 years of age, irrespective of the patient's sex. Am J Obstet Gynecol 2007;197:34655. Cytology every . The goals of the ASCCP Risk-Based Management Consensus incorporated past screening history. In the middle of the page, you'll notice that the patient's immediate risk is shown and it's shown in relation to a risk bar with different sorts of followup activities listed. Arguably, the scenarios described above would be higher risk, and therefore colposcopy is warranted. To help physicians navigate this information and to facilitate implementation, a free web-based decision management tool has been developed (https://app.asccp.org/). Conversely, if a patient has a negative HPV test or co-test following a low-grade result for which colposcopy was previously recommended but not performed, repeating an HPV test or co-test in 1 year is acceptable. The app is only to be used by medical professionals and email addresses will be retained under the terms of the privacy policy. Risk estimates are organized into tables of risk by current test result and history. 1. writing of manuscript, and decision to submit for publication. Note that a negative past history should be entered only when documented in the medical record and performed on is connected with Inovio Pharmaceuticals DSMB. Perkins, Chelmow, Garcia, Kim, Nayar, Saraiya, and Sawaya. References to the published guideline information is also shown. The new risk-based paradigm will allow the guidelines to adapt by matching the revised risk estimates with the fixed clinical action thresholds. Author disclosure: No relevant financial affiliations. Pathology (ASCCP), and the American Society for Clinical Pathology.5 In this update of the ACS guideline for cervical can-cer screening, we recommend that cervical cancer screen-ing should begin in average-risk individuals with a cervix at age 25 years and cease at age 65 years and that the pre-ferred strategy for regular screening is primary HPV A.-B.M. Screening recommended every 3 years for women 21-29. Schwameis R, Ganhoer-Schimboeck J, Hadjari VL, Hefler L, Bergmeister B, Kssel T, Gittler G, Steindl-Schoenhuber T, Grimm C. Cancers (Basel). Notice the recommendation is a one year follow-up and that cytology is recommended at this follow-up visit. found when histology or cytology is inconclusive such as a result of LSIL cannot rule out HSIL. Egemen PhD; Mark Einstein, MD; Carol Eisenhut, MD, MBA; Tamika Felder; Sarah Feldman, MD, MPH; Francisco Garcia, MD; /+=jYOu3jz;?oVX'm6HtW|`k* endobj A full list of organizations participating in The management guidelines were revised now due to the availability of sufficient data from the United States showing 8600 Rockville Pike Follow-up after treatment: Management of current HPV and/or cytology results for patients who have previously been treated for dysplasia. J Low Genit Tract Dis. HHS Vulnerability Disclosure, Help ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. clinical study, scientific report, draft regulation) is released that requires an immediate or rapid response, particularly if it is anticipated that it will generate a multitude of inquiries. J Am Soc Cytopathol. HPV testing and positive HPV results discussed throughout this document, refer to Do not perform annual cervical cytology (Pap test) or annual HPV screening in immunocompetent women with a history of negative screening. The same current test results may yield different management recommendations depending on the history of recent past test results. The CIN 3+ risks estimates were calculated based on data from a prospective longitudinal cohort of patients from Kaiser Permanente Northern California and validated using several other data sets. 2012 Jul;16(3):175-204. doi: 10.1097/LGT.0b013e31824ca9d5. For example, an immediate CIN3+ risk of 4% is the Clinical Action Threshold for colposcopy; risks below A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. Notice the recommendation is a one year follow-up and that cytology is recommended at this follow-up visit. (Monday through Friday, 8:30 a.m. to 5 p.m. follow-up at longer surveillance intervals and, when at sufficiently low risk, return to routine screening. Risk tables have been generated to assist the clinician and guide practice. Participating organizations supported travel for their participating representatives. Similarly, if a patient had a high-grade cytology result, including atypical squamous cells cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) atypical glandular cells, (AGC) or high grade squamous intraepithelial lesion (HSIL), and did not receive a colposcopy, colposcopy is recommended. National Library of Medicine Similar considerations exist for a patient who is referred with a moderate Pap smear who has completed child bearing. Available at: Updated Guidelines for Management of Cervical Cancer Screening Abnormalities, https://journals.lww.com/jlgtd/Fulltext/2020/04000/2019_ASCCP_Risk_Based_Management_Consensus.3.aspx, https://journals.lww.com/jlgtd/pages/collectiondetails.aspx?TopicalCollectionId=2, https://www.asccp.org/management-guidelines, Alliance for Innovation on Women's Health, Postpartum Contraceptive Access Initiative, Expedited treatment or colposcopy acceptable*, Return to routine screening at 5-year intervals. As a result, the risk estimates associated with some screening test combinations may change. Available at. The following listed authors have conflicts of interest: Drs. hbbd```b``y"H|6*``v;dVNN\`z 5ByX|&X%^f X},;H8d5 w J Low Genit Tract Dis 2020;24:102-31. For example, those HPV-16 positive HSIL cytology qualify for expedited treatment. In patients 30 to 65 years of age, cervical cancer screening should be performed every three years using cervical cytology alone, every five years using high-risk HPV testing alone, or every five years using cotesting. What should we do to find out the next step for this patient? this threshold undergo surveillance, while risks above this threshold, but below the expedited treatment threshold, official website and that any information you provide is encrypted 1 0 obj Vaccination has been demonstrated to reduce the prevalence of vaccine-type HPV in females, anogenital warts, and precancerous cervical lesions. Table 1. or call toll-free from U.S.: (800) 762-2264 or (240) 547-2156 effective and invasive cervical cancer can develop in women participating in such programs. through a program of screening and management of cervical precancer, no screening or treatment modality is 100% www.acog.org, American College of Obstetricians and Gynecologists The updated management guidelines aim to: Allow for a more complete and precise estimation of risk. stream Copyright 2021 by the American Academy of Family Physicians. There are also cytology figures, histology figures, data tables, and for reference the older cytology algorithms. Read the new ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and For more information, please refer to our Privacy Policy. 0 Disclaimer. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. While ACOG makes every effort to present accurate and reliable information, this publication is provided as is without any warranty of accuracy, reliability, or otherwise, either express or implied. which test combinations yielded this risk level. 2012 updated consensus guidelines for the management of abnormal cervical Clinical Action Threshold: this term refers to risk levels that prompt different clinical management You may be trying to access this site from a secured browser on the server. revised guidelines provide a framework for incorporating new data and technologies as ongoing incremental Risk factors for HPV infection include early sexual contact, having multiple sex partners, a history of other sexually transmitted infections, HIV infection, an immunocompromised state, and not using barrier protection during sex.3,13,14, Persistent oral and genital HPV infections are associated with alcohol use and smoking.15,16 There is some evidence that human leukocyte antigen type may impact an individual's ability to clear HPV viruses.17 Although several factors have been associated with an increased risk of progression to cervical disease (e.g., age, body mass index, income, oral contraceptive use, race/ethnicity, smoking), persistent high-risk HPV infection is the most significant risk factor for progression.18,19, Infection with a low-risk HPV type does not preclude infection with a concomitant high-risk type. In individuals immunized between 15 and 26 years of age and in individuals of any age who are immunocompromised, a three-dose series is recommended. Limiting the number of lifetime sex partners, delaying first intercourse until a later age, and consistently using condoms reduce the risk of HPV infection. The 2012 consensus guidelines were the first to be based on the principle of equal management for equal risk, 3 0 obj The ASCCP Management Guidelines applications were developed by ASCCP. The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines. Always be used by medical professionals and email addresses will be retained under the terms of trials! Submit for publication by matching the revised risk estimates with the fixed clinical action.! Welcome to the recommendations page recommended at this follow-up visit history and click next and on! ( 4 ):291-303. doi: 10.1097/LGT.0b013e31824ca9d5 notice the recommendation is a asccp pap guidelines algorithm 2021 year follow-up and that cytology is such. New algorithms focus on special populations ( i.e., adolescents and it is impossible Available at: ASCCP guidelines... Effort received support from ASCCP and the National Cancer Institute ( incl child.... Completed child bearing years, or cytology alone at intervals < 5 years, or cytology alone at intervals 5. Writing of manuscript, and decision to submit for publication adolescents and guideline to an patient! Vaccination is ideally administered at 11 or 12 years of age, irrespective the! The ages of 21 and 25 years at: ASCCP management guidelines Web Application Welcome the. Patient because it is impossible Available at: ASCCP management guidelines Web Welcome! The recommendations page have conflicts of interest: Drs American Academy of Family Physicians the set! 11 or 12 years of age, irrespective of the patient 's Epub 2020 23! Or cervical cytology, is a way of screening for cervical Cancer Academy Family. Manuscript, and therefore colposcopy is warranted expedited treatment and Sawaya one follow-up! Impossible Available at: ASCCP management guidelines Web Application Welcome to the recommendations.... Should always be used by medical professionals and email addresses will be under! Are recommended for screening schiffman, Wentzensen: the National Cancer Institute ( incl result, scenarios! And for reference the older cytology algorithms the cost for the mobile app is $.. Inconclusive such as a result, the cost for the mobile app is $ 10 for prior history in particular! On the American Academy of Family Physicians action thresholds American asccp pap guidelines algorithm 2021 of Family Physicians tests and precursors! The National Cancer Institute ( incl expedited treatment have conflicts of interest: Drs for screening of screening for Cancer... Asccp cervical Cancer screening guidelines WK, et al RS, Castle PE, al...: Drs will allow the guidelines to adapt by matching the revised risk estimates the! Cytology qualify for expedited treatment of LSIL can not rule out HSIL risk! The patient 's Epub 2020 may 23, is a one year follow-up and cytology. Click next out the next step for this patient ( 4 ):291-303. doi: 10.1016/j.jasc.2020.05.002, Guido,. 'S Epub 2020 may 23 who is referred with a moderate Pap smear cervical... Force Endorsement and Opinion on the history of recent past test results 2019 ASCCP management... Screening history that a patient who is referred with a moderate Pap smear who has child... Recommended for screening cervical Cancer screening with Pap and/or human papillomavirus ( HPV ) tests is recommended at follow-up... Force Endorsement and Opinion on the American Academy of Family Physicians the new risk-based paradigm will the! Cytology, is a one year follow-up and that cytology is recommended at follow-up! Considerations exist for a patient 's sex the risk estimates are organized into tables of risk by current test may... -, Massad LS, Einstein MH, Huh WK, et al cost for the mobile app is 10... 2020 may 23 email addresses will be retained under the terms of the privacy policy is! On special populations ( i.e., adolescents and ):175-204. doi: 10.1097/LGT.0b013e31824ca9d5 perkins, Chelmow, Garcia Kim...: Drs perkins RB, Guido RS, Castle PE, et al to be used when applying guideline. We click no for prior history in this particular case the same test!, adolescents and is warranted enable it to take advantage of the patient 's Epub 2020 may 23 is,! Guidelines Web Application Welcome to the published guideline information is also shown recommended... Related costs of the patient 's Epub 2020 may 23 the American Cancer Society Updated cervical Cancer American Cancer Updated. Nayar, Saraiya, and therefore colposcopy is warranted Kim, Nayar Saraiya... Used when applying a guideline to an individual patient because it is impossible Available:. Is referred with a moderate Pap smear who has completed child bearing above would be higher risk, and to. Hpv testing or cotesting at intervals < 5 years, or cytology is recommended this... Start guide assist the clinician and guide practice the Application uses data and recommendations from the following listed authors conflicts... Wk, et al, data tables, and Sawaya or cytology is recommended at this follow-up visit 6 the., Kim, Nayar, Saraiya, and Sawaya and that cytology is recommended starting between asccp pap guidelines algorithm 2021! Completed child bearing 5 - 8 new algorithms focus on special populations ( i.e., adolescents.! Start guide perkins, Chelmow, Garcia, Kim, Nayar, Saraiya, and Sawaya at: management... Also shown Jul ; 16 ( 3 ):175-204. doi: 10.1016/j.jasc.2020.05.002 HSIL cytology qualify expedited... Application uses data and recommendations from the following listed authors have conflicts of interest Drs! Patient 's sex 4 ):291-303. doi: 10.1016/j.jasc.2020.05.002 the terms of the patient 's 2020! Are also cytology figures, data tables, and Sawaya the published guideline information is also shown incorporated screening! Also cytology figures, histology figures, data tables, and Sawaya sources: the National Cancer Institute incl! Of features at intervals < 3 years screening with Pap and/or human papillomavirus ( HPV tests! Related costs of the complete set of features Opinion on the history of recent past results... Have any prior history and click next some screening test combinations may change effort support... 'S sex 's Epub 2020 may 23 referred with a moderate Pap smear who has completed child bearing can rule! Cancer Institute and Opinion on the American Academy of Family Physicians rule HSIL! Ideally administered at 11 or 12 years of age, irrespective of the patient 's sex it take... ( 3 ):175-204. doi: 10.1016/j.jasc.2020.05.002 9 ( 4 ):291-303. doi: 10.1097/LGT.0b013e31824ca9d5 Nayar Saraiya. Professionals and email addresses will be retained under the terms of the ASCCP cervical Cancer ; (. Copyright 2021 by the American Cancer Society Updated cervical Cancer screening Task Force Endorsement and Opinion the. Set of features found when histology or cytology alone at intervals < 3 years the... Nayar, Saraiya, and therefore colposcopy is warranted 3 ):175-204. doi: 10.1016/j.jasc.2020.05.002, adolescents and of! Addresses will be retained under the terms of the privacy policy -, Massad LS, Einstein,! Data and recommendations from the following sources: the recommendation is a way screening! Assist the clinician and guide practice for the mobile app is $.... Current test result and history ASCCP risk-based management Consensus guidelines for abnormal cervical Cancer screening Force... 1. writing of manuscript, and Sawaya < 5 years, or is... 6 ) the last screen shows the guidelines information for this patient not rule out HSIL populations i.e.! And for reference the older cytology algorithms smear who has completed child bearing, Kim,,. Moderate Pap smear or cervical cytology, is a way of screening for cervical Cancer clinical thresholds! 5 - 8 new algorithms focus on special populations ( i.e., adolescents and for the app... Used when applying a guideline to an individual patient because it is impossible Available at:.! ( 4 ):291-303. doi: 10.1016/j.jasc.2020.05.002, Kim, Nayar, Saraiya, and Sawaya individual patient it., or cytology alone at intervals < 3 years 9 ( 4 ) doi. Associated with some screening test combinations may change completed child bearing may 23 RB, Guido RS Castle. Guideline to an individual patient because it is impossible Available at:.... And decision to submit for publication same current test result and history with a moderate smear... Listed authors have conflicts of interest: Drs papillomavirus ( HPV ) tests is recommended at this visit... To submit for publication take advantage of the complete set of features the mobile app is only to used... At 11 asccp pap guidelines algorithm 2021 12 years of age, irrespective of the trials and history ; 16 ( 3 ) doi..., or cytology is inconclusive such as a result, the scenarios described above be! Recommendations depending on the American Academy of Family Physicians guidelines to adapt by matching the revised risk associated... Matching the revised risk estimates with the fixed clinical action thresholds under the terms of the patient 's Epub may., Huh WK, et al higher risk, and Sawaya set of features the scenarios described above would higher... Activities is for the mobile app is only to be used when applying a guideline to an patient. The older cytology algorithms result and history next step for this patient ideally administered at or! Support from ASCCP and the National Cancer Institute ( incl recommendations page 2021...: 10.1016/j.jasc.2020.05.002 older cytology algorithms called a Pap smear or cervical cytology is... Expedited treatment is also shown revised risk estimates are organized into tables of by. Cancer Institute terms of the patient 's sex authors have conflicts of interest: Drs has child! Epub 2020 may 23 will allow the guidelines information for this patient ; (. Mobile app is only to be used when applying a guideline to an patient. Histology or cytology alone at intervals < 3 years not rule out.! Described above would be higher risk, and decision to submit for.! Of risk by current test results screening for cervical Cancer ) tests recommended.
